Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Clinical Data, Vital Diagnostics B.V. deal

CLDA sold its Electa Lab s.r.l. business to Vital Diagnostics for $2.5

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE